Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01719 | 34640643 | J Clin Med | Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver. | 2021 | Details |
| A01720 | 34640482 | J Clin Med | Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A01721 | 34639207 | Int J Mol Sci | Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis. | 2021 | Details |
| A01722 | 34639029 | Int J Mol Sci | Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio. | 2021 | Details |
| A01723 | 34638941 | Int J Mol Sci | MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01724 | 34638880 | Int J Mol Sci | A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. | 2021 | Details |
| A01725 | 34638640 | Int J Mol Sci | Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. | 2021 | Details |
| A01726 | 34638217 | Zhonghua Gan Zang Bing Za Zhi | [Advances in the study of the role of adenosine 2A receptor in liver injury]. | 2021 | Details |
| A01727 | 34638206 | Zhonghua Gan Zang Bing Za Zhi | [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu]. | 2021 | Details |
| A01728 | 34635855 | Nat Med | ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. | 2021 | Details |
| A01729 | 34635626 | Gut Liver | Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease. | 2022 | Details |
| A01731 | 34634561 | Biomed Pharmacother | Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice. | 2021 | Details |
| A01732 | 34634521 | Mol Metab | STE20-type kinase TAOK3 regulates hepatic lipid partitioning. | 2021 | Details |
| A01733 | 34633706 | Hepatology | Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. | 2021 | Details |
| A01734 | 34633105 | Aliment Pharmacol Ther | Dose-response relationships of accelerometer-measured sedentary behaviour and physical activity with non-alcoholic fatty liver disease. | 2021 | Details |
| A01735 | 34632902 | Expert Rev Gastroenterol Hepatol | Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis. | 2021 | Details |
| A01736 | 34632700 | Mol Nutr Food Res | Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet. | 2021 | Details |
| A01737 | 34632357 | J Transl Autoimmun | Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis. | 2021 | Details |
| A01738 | 34631329 | Biosci Microbiota Food Health | Effects of a high-γ-polyglutamic acid-containing natto diet on liver lipids and cecal microbiota of adult female mice. | 2021 | Details |
| A01739 | 34631140 | Obes Sci Pract | "Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD". | 2021 | Details |
| A01740 | 34631129 | Obes Sci Pract | Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study. | 2021 | Details |
| A01741 | 34630909 | World J Diabetes | Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis. | 2021 | Details |
| A01742 | 34630901 | World J Diabetes | Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? | 2021 | Details |
| A01743 | 34630878 | World J Hepatol | Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. | 2021 | Details |
| A01744 | 34630869 | World J Hepatol | Coronavirus disease 2019 and non-alcoholic fatty liver disease. | 2021 | Details |
| A01745 | 34630157 | Front Physiol | Effect of Exercise Training on Fat Loss-Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution. | 2021 | Details |
| A01746 | 34630100 | Front Pharmacol | CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway. | 2021 | Details |
| A01747 | 34629804 | World J Gastroenterol | Screening for nonalcoholic fatty liver disease-when, who and how? | 2021 | Details |
| A01748 | 34629802 | World J Gastroenterol | Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood. | 2021 | Details |
| A01749 | 34629799 | World J Gastroenterol | Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. | 2021 | Details |
| A01750 | 34629256 | Nutr Metab Cardiovasc Dis | Extent and features of liver steatosis in vitro pave the way to endothelial dysfunction without physical cell-to-cell contact. | 2021 | Details |
| A01751 | 34629064 | Lipids Health Dis | Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan. | 2021 | Details |
| A01752 | 34629059 | Lipids Health Dis | The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. | 2021 | Details |
| A01753 | 34629056 | Lipids Health Dis | Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. | 2021 | Details |
| A01754 | 34629052 | Lipids Health Dis | Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. | 2021 | Details |
| A01755 | 34628896 | Ann Palliat Med | Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus. | 2021 | Details |
| A01756 | 34628383 | Georgian Med News | THE INFLUENCE OF HYPERCHOLESTEROLEMIA AND CONCOMITANT STATIN THERAPY ON THE STATE OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A01757 | 34628102 | Atherosclerosis | IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A01758 | 34627976 | J Hepatol | Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. | 2021 | Details |
| A01759 | 34627751 | Am J Pathol | Hepatic Steatosis in the Mouse Model of Wilson Disease Coincides with a Muted Inflammatory Response. | 2021 | Details |
| A01760 | 34627696 | Nutr Metab Cardiovasc Dis | Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study. | 2021 | Details |
| A01761 | 34627692 | Nutr Metab Cardiovasc Dis | Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. | 2021 | Details |
| A01762 | 34626855 | Mol Metab | The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. | 2021 | Details |
| A01763 | 34626841 | Cell Mol Gastroenterol Hepatol | Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. | 2021 | Details |
| A01764 | 34626833 | Clin Gastroenterol Hepatol | Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. | 2021 | Details |
| A01765 | 34626589 | J Lipid Res | Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70-/- mice by reducing fat absorption. | 2021 | Details |
| A01766 | 34626331 | Hepatol Int | Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study. | 2021 | Details |
| A01767 | 34624564 | Clin Gastroenterol Hepatol | Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary Care. | 2021 | Details |
| A01768 | 34624333 | J Lipid Res | Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet. | 2021 | Details |
| A01769 | 34624198 | Expert Rev Gastroenterol Hepatol | Current epidemiology in hepatocellular carcinoma. | 2021 | Details |
| A01770 | 34622555 | Diabetes Obes Metab | Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. | 2021 | Details |
| A01771 | 34622234 | Cell Rep Med | Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota. | 2021 | Details |
| A01772 | 34622192 | Metabol Open | Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults. | 2021 | Details |
| A01773 | 34622006 | JGH Open | Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score. | 2021 | Details |
| A01774 | 34621822 | World J Clin Cases | Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01775 | 34621326 | Evid Based Complement Alternat Med | A Novel Identified Peptide Hormone "Metabolitin" Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway. | 2021 | Details |
| A01776 | 34621170 | Front Pharmacol | Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy via ANT-AMPK-mTORC1 Signaling Pathway. | 2021 | Details |
| A01777 | 34621168 | Front Pharmacol | Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics. | 2021 | Details |
| A01778 | 34621052 | Nat Med | Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. | 2021 | Details |
| A01779 | 34620897 | Sci Rep | A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men. | 2021 | Details |
| A01780 | 34620653 | BMJ Open | Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation. | 2021 | Details |
| A01781 | 34619251 | J Hepatol | Asian perspective on NAFLD-associated HCC. | 2021 | Details |
| A01782 | 34619105 | Lancet Diabetes Endocrinol | COVID-19 and metabolic disease: mechanisms and clinical management. | 2021 | Details |
| A01783 | 34619074 | Cell Metab | Molecular aspects of fructose metabolism and metabolic disease. | 2021 | Details |
| A01784 | 34619026 | Liver Int | The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta-analysis. | 2021 | Details |
| A01785 | 34618982 | FASEB J | Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A01786 | 34618619 | Scand J Gastroenterol | Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care. | 2021 | Details |
| A01787 | 34618611 | Immunopharmacol Immunotoxicol | Capillin protects against non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation and oxidative stress. | 2021 | Details |
| A01788 | 34617537 | Food Funct | Kombuchas from green and black teas reduce oxidative stress, liver steatosis and inflammation, and improve glucose metabolism in Wistar rats fed a high-fat high-fructose diet. | 2021 | Details |
| A01789 | 34617207 | Obes Surg | Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus. | 2021 | Details |
| A01790 | 34617180 | Bull Exp Biol Med | Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β. | 2021 | Details |
| A01791 | 34616724 | Front Cell Dev Biol | Comprehensive Analysis of NAFLD and the Therapeutic Target Identified. | 2021 | Details |
| A01792 | 34615918 | Sci Rep | Electrical impedance tomography for non-invasive identification of fatty liver infiltrate in overweight individuals. | 2021 | Details |
| A01793 | 34615727 | Gut | Novel therapeutic targets for cholestatic and fatty liver disease. | 2021 | Details |
| A01794 | 34614409 | Cell Metab | DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. | 2021 | Details |
| A01795 | 34613814 | Sci Transl Med | Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. | 2021 | Details |
| A01796 | 34611618 | JHEP Rep | External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population. | 2021 | Details |
| A01797 | 34611524 | J Hepatocell Carcinoma | An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. | 2021 | Details |
| A01798 | 34611144 | Cell Death Discov | Ferroptosis in liver disease: new insights into disease mechanisms. | 2021 | Details |
| A01799 | 34610926 | BMJ Open Gastroenterol | Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt. | 2021 | Details |
| A01800 | 34610720 | Diabetes Metab J | Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. | 2021 | Details |
| A01801 | 34610207 | Liver Int | Association of genetic variations with NAFLD in lean individuals. | 2021 | Details |
| A01802 | 34609305 | Turk J Gastroenterol | Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis. | 2021 | Details |
| A01803 | 34609304 | Turk J Gastroenterol | Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis. | 2021 | Details |
| A01804 | 34609237 | Health Informatics J | Trend research of vitamin D receptor: Bibliometric analysis. | 2021 | Details |
| A01805 | 34609086 | United European Gastroenterol J | Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease. | 2021 | Details |
| A01806 | 34608587 | Hepatol Int | Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease. | 2021 | Details |
| A01807 | 34607492 | Angiology | Pancretic Fat Accummulation is Associated with Subclinical Atherosclerosis. | 2021 | Details |
| A01808 | 34607257 | Biochem Biophys Res Commun | The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver. | 2021 | Details |
| A01809 | 34607067 | Clin Res Hepatol Gastroenterol | Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis. | 2021 | Details |
| A01810 | 34607007 | Fish Shellfish Immunol | Polysaccharide extract from pomelo fruitlet ameliorates diet-induced nonalcoholic fatty liver disease in hybrid grouper (Epinephelus lanceolatus♂ × Epinephelus fuscoguttatus♀). | 2021 | Details |
| A01811 | 34606980 | Endocr Pract | Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A01812 | 34606913 | J Hepatol | Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. | 2021 | Details |
| A01813 | 34606912 | J Hepatol | Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it? | 2021 | Details |
| A01815 | 34606548 | Food Funct | Sesamol supplementation alleviates nonalcoholic steatohepatitis and atherosclerosis in high-fat, high carbohydrate and high-cholesterol diet-fed rats. | 2021 | Details |
| A01816 | 34606532 | Food Funct | Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice. | 2021 | Details |
| A01818 | 34604973 | Eur Rev Med Pharmacol Sci | Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. | 2021 | Details |
| A01819 | 34604287 | Front Nutr | Transcriptomic Analysis Reveals a Sex-Dimorphic Influence of GAT-2 on Murine Liver Function. | 2021 | Details |
| A01820 | 34604283 | Front Nutr | Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats. | 2021 | Details |
| A01821 | 34604271 | Front Nutr | Mechanism of Paeoniae Radix Alba in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement. | 2021 | Details |